ST. LOUIS, April 17, 2013 /PRNewswire/ -- The BIO International Convention is the largest annual event for the biotechnology industry. This year's meeting will feature two leading strategy experts, Rita E. Numerof, Ph.D., President, and Michael N. Abrams, M.A., Managing Partner of Numerof & Associates, Inc. They will share perspectives drawn from more than 25 years of experience working globally across healthcare.
They are each moderating panel sessions on April 23. Rita's session, titled Massive Health Care Consolidation and Its Impact on Biotech, is scheduled for 10:30am. She'll be joined by Paul Howard, Ph.D. (Manhattan Institute), and Marc Boutin (National Health Council) in a discussion of how biotech companies can adapt to a more consolidated marketplace.
Michael's session, at 3:45pm, is titled Demonstrating Product Economic and Clinical Value: Know What Investors Are Looking For. He, Alexander Natz, Ph.D. (European Confederation of Pharmaceutical Entrepreneurs), Art Pappas (Pappas Ventures), and Chris Seaton (Bayer AG) will discuss how biotech companies can evaluate their products' value and communicate that value to investors.
Rita and Michael will sign copies of their most recent book, Healthcare at a Turning Point, after their sessions.
2013 BIO International Convention
About Rita Numerof
An internationally recognized consultant, Rita works in dynamic industries like healthcare that are challenged to develop new business models to adapt to major market changes. Rita's expertise has helped a wide range of leading companies to fundamentally reshape and execute new strategy. Her global cross-industry perspective and expertise in strategy execution are the basis for objective counsel that leading executives tap into on a regular basis. She is widely published in business journals and has authored five books, including Healthcare at a Turning Point: A Roadmap for Change (2013).
About Michael Abrams
Over the past 25 years, Michael has built a portfolio of strategy and business performance successes as both an internal and external consultant for Fortune 500 corporations on a global basis. Michael is well known for his expertise in the emerging demand for economic and clinical value, and has helped clients develop processes and capabilities to successfully compete in highly dynamic markets. Michael has written extensively on the need for integrated, systemic solutions to the challenges facing the healthcare industry, and has co-authored two books, including Healthcare at a Turning Point: A Roadmap for Change (2013).
SOURCE Numerof & Associates, Inc.